Skip to main content
Premium Trial:

Request an Annual Quote

BD's Q2 Revenues Drop Slightly While Biosciences Biz Rises 3 Percent

NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its second-quarter revenues were down less than 1 percent year over year, but its BD Biosciences segment managed three percent revenue growth for the quarter.

The Franklin Lakes, NJ-based maker of diagnostics, medical products, and life science research tools reported revenues of $1.74 billion for the three-month period ended March 31, down from revenues of $1.75 billion in the second quarter of 2008.

Its Biosciences business segment had revenues of $303.8 million for the quarter, up 3 percent from revenues of $294.1 million for Q2 2008. The segment's revenues include a .7 percent positive impact from currency translation.

The BD Medical segment had revenues of $897.3 million for the quarter, down around 3 percent from $922.3 million, and including a nearly 5 percent negative impact from currency translation. The BD Diagnostics segment had revenues of 539.6 million, up 1.7 percent from revenues of $530.6 million for the second quarter of 2008, and including a negative foreign currency impact of around 3 percent.

BD's net income for Q2 was $261.3 million, or $1.06 per share, down from $276.2 million, or $1.09 per share, for Q2 2008.

Its R&D expenses increased roughly 3 percent to $98.7 million from $96 million, while its SG&A spending rose 6 percent to $440.5 million from $415.5 million.

BD did not report its cash position as of the end of the second quarter.

The firm expects to report EPS growth of between 7 percent and 9 percent for full-year 2009.

Filed under

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.